Limitations of fluorocarbons in reducing myocardial infarct size
- 1 March 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (6) , 830-834
- https://doi.org/10.1016/0002-9149(85)90165-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining techniquePublished by Elsevier ,2004
- Reduction of myocardial infarct size by a fluorocarbon-oxygenated reperfusateThe American Journal of Cardiology, 1984
- Reassessment of Criteria for the Selection of Perfluorochemicals for Second‐Generation Blood Substitutes: Analysis of Structure/Property RelationshipsArtificial Organs, 1984
- Noninvasive quantification of jeopardized myocardial mass in dogs using 2-dimensional echocardiography and thallium-201 tomographyThe American Journal of Cardiology, 1983
- Effect of fluocarbon exchange transfusion on myocardial infarction size in dogsThe American Journal of Cardiology, 1983
- Effects of reduced coronary flow on thallium-201 accumulation and release in an in vitro rat heart preparationThe American Journal of Cardiology, 1983
- Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: Reduction or delay?The American Journal of Cardiology, 1983
- Influence of the extent of the zone at risk on the effectiveness of drugs in reducing infarct size.Circulation, 1982
- Fluorocarbons Reduce Myocardial Ischemic Damage After Coronary OcclusionScience, 1981
- Some statistical methods useful in circulation research.Circulation Research, 1980